Internal Medicine, Pulmonary Disease · Clarksville, TN
NPI
1114024908
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
298 Clear Sky Ct, Suite B
Clarksville, TN, 37043
Phone (931) 542-2647
Groups this clinician bills Medicare through
Medicare paid, 2024
$155K
2,382 services
Medicare patients, 2024
638
Average age 72
Drug cost, 2024
$2.4M
3,175 prescriptions
Company payments, 2025
$17.38
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sriram Krishnasamy was code 99214 (office e&m - established), 833 times for 394 patients. In total Sriram Krishnasamy billed 2,382 services in 27 codes, and Medicare paid $155K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 833 | 394 | $94.21 | $78K |
| 94729 Pulmonary Function Testing | Office | 277 | 275 | $39.04 | $11K |
| 94727 Pulmonary Function Testing | Office | 277 | 275 | $31.64 | $8,765 |
| 99213 Office E&M - Established | Office | 250 | 185 | $60.38 | $15K |
| 94010 Pulmonary Function Testing | Office | 233 | 231 | $19.44 | $4,530 |
| 99203 Office E&M - New | Office | 110 | 110 | $71.28 | $7,841 |
| 99291 Critical Care E&M | Facility | 80 | 34 | $168.55 | $13K |
| 94060 Pulmonary Function Testing | Office | 52 | 52 | $27.13 | $1,411 |
| 94060 Pulmonary Function Testing | Facility | 42 | 39 | $7.91 | $332 |
| 99232 Hospital E&M - Subsequent | Facility | 42 | 24 | $62.27 | $2,615 |
| 99204 Office E&M - New | Office | 33 | 33 | $119.98 | $3,959 |
| 94729 Pulmonary Function Testing | Facility | 29 | 29 | $6.78 | $197 |
| 94727 Pulmonary Function Testing | Facility | 29 | 29 | $9.17 | $266 |
| 99233 Hospital E&M - Subsequent | Facility | 17 | 14 | $94.37 | $1,604 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $102.92 | $1,338 |
By year: 2022 $146K for 2,224 services; 2023 $142K for 2,382 services; 2024 $155K for 2,382 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sriram Krishnasamy prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 852 prescriptions and refills. In total Sriram Krishnasamy wrote 3,175 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 852 | 1,734 | 360 | $24K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 341 | 598 | 108 | $379K |
| Spiriva Respimat Tiotropium Bromide | 128 | 256 | 43 | $135K |
| Symbicort Budesonide/Formoterol Fumarate | 127 | 209 | 45 | $49K |
| Cefdinir Generic | 115 | 115 | 96 | $1,529 |
| Azithromycin Generic | 111 | 257 | 48 | $1,708 |
| Advair Hfa Fluticasone Propion/Salmeterol | 108 | 177 | 33 | $57K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 106 | 165 | 31 | $103K |
| Prednisone Generic | 92 | 114 | 56 | $268 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 92 | 150 | 46 | $33K |
| Montelukast Sodium Generic | 77 | 188 | 30 | $941 |
| Ofev Nintedanib Esylate | 70 | 70 | 12 | $928K |
| Ventolin Hfa Albuterol Sulfate | 59 | 120 | 23 | $5,134 |
| Spiriva Handihaler Tiotropium Bromide | 55 | 95 | 15 | $48K |
| Xarelto Rivaroxaban | 54 | 54 | Under 11 | $29K |
Brand drugs: 1,779 claims; generic drugs: 1,396 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sriram Krishnasamy $17.38 ($17.38 in general payments such as food, travel and fees) from 1 company. The largest payer was Insmed, Inc. with $17.38.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 1 | $17.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.